CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
41 research outputs found
Midostaurin does not prolong cardiac repolarization defined in a thorough electrocardiogram trial in healthy volunteers
Author
AC Garcia-Montero
Adam del Corral
+26 more
Alice Huntsman-Labed
AW Tolcher
B Darpo
C Dutreix
Catherine Dutreix
CE Garnett
DG Gilliland
DJ DeAngelo
F Breitenbuecher
GJ Noel
H Stass
J Gotlib
JA Florian
Joel Morganroth
JW Mason
KW Pratz
RJ Simes
RM Stone
Robert Harrell
S Kayser
Sebastien Lorenzo
SK Sarkar
T Fischer
TF Chu
Y Wang
Yanfeng Wang
Publication venue
Springer-Verlag
Publication date
01/01/2012
Field of study
Get PDF
Crossref
Springer - Publisher Connector
PubMed Central
Plasma protein binding of sorafenib, a multi kinase inhibitor: in vitro and in cancer patients
Author
A Awada
B. Douglas Smith
+19 more
C Lathia
D Strumberg
GM Pacifici
H Rosing
JD Wright
John J. Wright
JW Clark
Keith W. Pratz
KW Pratz
L Jain
L Li
Linping Xu
M Moore
M Zhao
Maria Cristina Villarroel
Michelle A. Rudek
N Rossing
PR Jackson
S Wilhelm
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia
Author
AA Wurm
BC Shaffer
+12 more
CC Smith
D Gerloff
F Stölzel
H Döhner
H Döhner
KW Pratz
MH Ree van der
MS Tallman
S Göllner
SP Whitman
TJ Ley
X Pan
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
Acquired isodisomy on chromosome 13 at diagnosis results in impaired overall survival in patients with FLT3-ITD mutant acute myeloid leukaemia
Author
BD Cheson
BH Lee
+13 more
C Green
D Grimwade
DC Linch
KW Pratz
M Griffiths
M Pratcorona
M Raghavan
PD Kottaridis
PD Kottaridis
RF Schlenk
RF Schlenk
S Kharazi
SP Whitman
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
A pharmacodynamic study of sorafenib in patients with relapsed and refractory acute leukemias
Author
A Awada
BD Cheson
+32 more
BD Smith
BI Rini
C Lathia
C Yu
D Strumberg
D Strumberg
FK Tong
GK Abou-Alfa
JW Clark
KW Pratz
KW Pratz
M Gibaldi
M Levis
M Levis
M Moore
M Zhao
MR Ricciardi
MS Tallman
NN Safaian
O Kretz
P Brown
P Brown
RA Hilger
RC Kane
RW Stam
S Larson
S Metzelder
SM Kornblau
SM Wilhelm
VP Shah
W Zhang
XW Meng
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
A phase I/II study of sorafenib in combination with low dose cytarabine in elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome from the National Cancer Institute of Canada Clinical Trials Group: trial IND.186
Author
Alison Foo
Brian Leber
+14 more
Cheson BD
Cheson BD
David A. Macdonald
Elizabeth A. Eisenhauer
Joseph Brandwein
Lowenberg B
Pratz KW
Sarit E. Assouline
Stephen Caplan
Stephen Couban
Suzanne Kamel-Reid
Tilly H
Wendy Walsh
Whitman SP
Publication venue
'Informa UK Limited'
Publication date
Field of study
No full text
Crossref
Healthcare expenses for treatment of acute myeloid leukemia
Author
AM HN N
Amer M. Zeidan
+20 more
Bae YH
Batty N
Deutsch YE
Halpern AB
Horster L
Irish W
Jan Philipp Bewersdorf
Kansal A
Lane JD
Mahmoud D
Majhail NS
Meyers J
Noone AM
Pratz KW
Rong Wang
Rory M. Shallis
Sarah Perreault
Scott F. Huntington
Tremblay G
Xiaomei Ma
Publication venue
'Informa UK Limited'
Publication date
Field of study
No full text
Crossref
Development of Midostaurin as a Tyrosine Kinase Inhibitor
Author
A del Corral
A Pandey
+66 more
AM O’Farrell
BD Smith
C Reindl
CB Williams
CC Smith
D Auclair
D Fabbro
DJ Propper
DL Stirewalt
E Lierman
E Weisberg
E Weisberg
EJ Rombouts
ER Mardis
EV Barry
F Hayakawa
F Heidel
F Stolzel
G Ramsingh
I Utz
J Budworth
J Gotlib
J Gotlib
J How
JD Growney
K Mrozek
K Ozeki
KT Kim
KW Pratz
KW Pratz
KW Yee
L Bullinger
M Levis
M Levis
M Rahmani
M Yanada
M Zhao
MG Mohi
N Bubnoff von
P Brown
PD Kottaridis
PH Wiernik
PP Zarrinkar
R Zheng
RE Gale
RF Schlenk
RK Kancha
RM Stone
RM Stone
RR Rosato
S Frohling
S Knapper
S Metzelder
SM Wilhelm
SP Whitman
SS Alkan
T Fischer
T Meyer
T Sato
W Fiedler
W Zhang
WF Tam
Y Ikegami
Y Ikegami
Y Yamamoto
Z Zeng
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
New drugs creating new challenges in acute myeloid leukemia
Author
Ahmed S
Andrew H. Wei
+31 more
Assi R
Barbier V
Chien S
Cortes J
Cortes JE
Daver N
Daver NG
DeAngelo DJ
Delaunay J
DiNardo CD
Döhner K
Garcia Manero G
Garcia‐Manero G
Goldberg AD
Goldberg AD
Hansen E
Ing S. Tiong
Larson RA
Nakao M
Oliva EN
Pollyea DA
Pratz KW
Ravandi F
Roboz GJ
Sallman DA
Sallman DA
Stein EM
Strickland S
Uy GL
Wang ES
Winkler IG
Publication venue
'Wiley'
Publication date
01/12/2019
Field of study
No full text
Crossref
Monash University Research Portal
The combination of FLT3 and DNA methyltransferase inhibition is synergistically cytotoxic to FLT3/ITD acute myeloid leukemia cells
Author
A Sexauer
AF Cashen
+30 more
AT Fathi
C Flotho
CC Smith
CH Man
DA Pollyea
ER Plimack
F Ravandi
H Konig
H Serve
HM Kantarjian
J Aimiuwu
KW Pratz
M Levis
M Levis
M Levis
M Lubbert
MR Grunwald
N Sudan
P Fenaux
PP Zarrinkar
PW Hollenbach
R Zheng
S Agrawal
W Zhang
X Yang
Y Matsuo
Y Saunthararajah
Y Saunthararajah
YB Chen
YF Wong
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
1
2
3
4
last